Federico Rossari

810 total citations · 1 hit paper
19 papers, 429 citations indexed

About

Federico Rossari is a scholar working on Oncology, Molecular Biology and Hepatology. According to data from OpenAlex, Federico Rossari has authored 19 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Hepatology. Recurrent topics in Federico Rossari's work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and CAR-T cell therapy research (3 papers). Federico Rossari is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and CAR-T cell therapy research (3 papers). Federico Rossari collaborates with scholars based in Italy, Germany and Japan. Federico Rossari's co-authors include Enrico Orciuolo, Filippo Minutolo, Gabriele Buda, Luigi Naldini, Nadia Coltella, Stefano Colombo, Massimo Bellini, Renato Ostuni, Brigida Barberio and Chiara Brombin and has published in prestigious journals such as Journal of the American College of Cardiology, Annals of Oncology and Science Translational Medicine.

In The Last Decade

Federico Rossari

12 papers receiving 423 citations

Hit Papers

Past, present, and future of Bcr-Abl inhibitors: from che... 2018 2026 2020 2023 2018 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy
    2018 254 citations Federico Rossari, Filippo Minutolo et al. Journal of Hematology & Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Federico Rossari Italy 7 179 145 122 88 58 19 429
Justin Cidado United States 12 394 2.2× 187 1.3× 91 0.7× 46 0.5× 63 1.1× 36 561
Patricia Balsas Spain 10 290 1.6× 153 1.1× 133 1.1× 62 0.7× 81 1.4× 14 449
Lee Wisner United States 8 216 1.2× 194 1.3× 61 0.5× 46 0.5× 117 2.0× 21 544
Anniina Virtanen Finland 10 125 0.7× 250 1.7× 98 0.8× 128 1.5× 151 2.6× 17 570
Gérald Massonnet France 9 208 1.2× 192 1.3× 126 1.0× 72 0.8× 55 0.9× 10 482
Lucy Gong United States 11 210 1.2× 294 2.0× 47 0.4× 148 1.7× 134 2.3× 16 608
Bárbara Du Rocher Brazil 12 285 1.6× 133 0.9× 62 0.5× 150 1.7× 64 1.1× 19 496
Marcelo J. Murai United States 9 596 3.3× 91 0.6× 224 1.8× 46 0.5× 32 0.6× 17 769
Grégory Ehx Belgium 16 270 1.5× 213 1.5× 262 2.1× 85 1.0× 294 5.1× 39 696
Melissa Q. McCreery United States 6 181 1.0× 85 0.6× 160 1.3× 78 0.9× 26 0.4× 9 370

Countries citing papers authored by Federico Rossari

Since Specialization
Citations

This map shows the geographic impact of Federico Rossari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federico Rossari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federico Rossari more than expected).

Fields of papers citing papers by Federico Rossari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federico Rossari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federico Rossari. The network helps show where Federico Rossari may publish in the future.

Co-authorship network of co-authors of Federico Rossari

This figure shows the co-authorship network connecting the top 25 collaborators of Federico Rossari. A scholar is included among the top collaborators of Federico Rossari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federico Rossari. Federico Rossari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Rossari, Federico, Giorgia Alvisi, Melania Cusimano, et al.. (2025). A cross-talk established by tumor-targeted cytokines rescues CAR T cell activity and engages host T cells against glioblastoma in mice. Science Translational Medicine. 17(805). eado9511–eado9511. 1 indexed citations
2.
3.
Camera, Silvia, Federico Rossari, Silvia Foti, et al.. (2025). HER2 Pathway in Biliary Tract Cancer: A Snapshot of the Current Understanding and Future Directions. Targeted Oncology. 20(2). 269–280.
4.
Rossari, Federico, Gualtiero Alvisi, Michael D. Cusimano, et al.. (2024). 52P Tumor-targeted cytokine release by genetically-engineered myeloid cells rescues CAR-T activity and engages endogenous T cells against high-grade glioma in mouse models. Immuno-Oncology Technology. 24. 100863–100863.
5.
Foti, Silvia, Silvia Camera, Federico Rossari, et al.. (2024). Developing targeted therapeutics for hepatocellular carcinoma: a critical assessment of promising phase II agents. Expert Opinion on Investigational Drugs. 33(8). 839–849.
6.
7.
8.
Rossari, Federico, Silvia Foti, Silvia Camera, et al.. (2024). Treatment options for advanced hepatocellular carcinoma: the potential of biologics. Expert Opinion on Biological Therapy. 24(6). 455–470. 3 indexed citations
9.
Rossari, Federico, Marianna Silletta, Silvia Foti, et al.. (2024). Intermediate hepatocellular carcinoma: new horizons and prospects for our patients. Expert Review of Gastroenterology & Hepatology. 18(10). 661–672.
10.
Beretta, Stefano, Federico Rossari, Nadia Coltella, et al.. (2023). The transcription factor HIF2α partakes in the differentiation block of acute myeloid leukemia. EMBO Molecular Medicine. 15(11). e17810–e17810. 6 indexed citations
11.
Rossari, Federico, et al.. (2023). Gene-based delivery of immune-activating cytokines for cancer treatment. Trends in Molecular Medicine. 29(4). 329–342. 15 indexed citations
12.
Licata, Luca, Marco Giovanni Mariani, Federico Rossari, et al.. (2023). Tissue- and liquid biopsy-based biomarkers for immunotherapy in breast cancer. The Breast. 69. 330–341. 9 indexed citations
13.
Rossari, Federico, Toshifumi Tada, Masatoshi Kudo, et al.. (2023). 185P Disease etiology impact on outcomes of hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: A real-world, multicenter study. Annals of Oncology. 34. S1547–S1547. 2 indexed citations
14.
Rossari, Federico, Francesco Vitiello, Valentina Burgio, et al.. (2023). Past, present, and future of FGFR inhibitors in cholangiocarcinoma: from biological mechanisms to clinical applications. Expert Review of Clinical Pharmacology. 16(7). 631–642. 1 indexed citations
15.
Cusimano, Melania, Federico Rossari, Stefano Beretta, et al.. (2022). Targeted inducible delivery of immunoactivating cytokines reprograms glioblastoma microenvironment and inhibits growth in mouse models. Science Translational Medicine. 14(653). eabl4106–eabl4106. 54 indexed citations
16.
Bertani, Lorenzo, Federico Rossari, Brigida Barberio, et al.. (2020). Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated With Anti-TNF: Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio. Inflammatory Bowel Diseases. 26(10). 1579–1587. 47 indexed citations
17.
Rossari, Federico, et al.. (2019). Tumor dormancy as an alternative step in the development of chemoresistance and metastasis - clinical implications. Cellular Oncology. 43(2). 155–176. 36 indexed citations
18.
Borrelli, Chiara, Francesco Gentile, Federico Rossari, et al.. (2018). PERSISTENCE OF PERIODIC BREATHING/CHEYNE-STOKES RESPIRATION AFTER TILT TABLE TEST DURING SHORT TERM RESPIRATORY MONITORING IN PATIENTS WITH SYSTOLIC HEART FAILURE. Journal of the American College of Cardiology. 71(11). A923–A923. 1 indexed citations
19.
Rossari, Federico, Filippo Minutolo, & Enrico Orciuolo. (2018). Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy. Journal of Hematology & Oncology. 11(1). 84–84. 254 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Justin Cidado Breakdown of academic impact, for papers by Patricia Balsas Breakdown of academic impact, for papers by Lee Wisner Breakdown of academic impact, for papers by Anniina Virtanen Breakdown of academic impact, for papers by Gérald Massonnet Breakdown of academic impact, for papers by Lucy Gong Breakdown of academic impact, for papers by Bárbara Du Rocher Breakdown of academic impact, for papers by Marcelo J. Murai Breakdown of academic impact, for papers by Grégory Ehx Breakdown of academic impact, for papers by Melissa Q. McCreery
Rankless by CCL
2026